4th Quarter - Report

TARPLIN, DOWNS & YOUNG, LLC for AMGEN INC

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

**see addendum page PL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation ***, no specific bill, Prescription Drug User Fee Act (PDUFA) and associated policies

LobbyistCovered position, as disclosed
RAISSA H DOWNS —
MICHELLE P EASTON —
ISAAC A FORDJOUR —
LINDA E TARPLIN —
JENNIFER B YOUNG —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

**see addendum page Medicare Coverage and Reimbursement Issues H.R. 5 - Protecting Access to Healthcare Act H.R. 8 - American Taypayer Relief Act of 2012, ESRD ***, no specific bill number, reimbursement issues, Medicare Part B reimbursement and coverage of dialysis products

LobbyistCovered position, as disclosed
RAISSA H DOWNS Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst.
MICHELLE P EASTON Chief Health Counsel, Sen. Cmte. On Finance;
ISAAC A FORDJOUR —
LINDA E TARPLIN Congressman Billy Tauzin
JENNIFER B YOUNG Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5 (112th), H.R. 8 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.